Doctor of Osteopathy Program year 2020 Reported 2019–2020 Source: CMS Open Payments, 2026 publication

Stuart Stoller

Family Medicine Sterling Heights, MI Doctor of Osteopathy

NPI 1184665713 CMS profile 144096

37450 Dequindre Rd, Sterling Heights, MI 48310

Open in the dashboard

General payments

$4,501

268 records reported · program years 2019–2020

Research payments

$0

Paid to them · None reported · program years 2019–2020

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$136,265 paid to institutions, not to them · program years 2019–2023

Through program year 2020, Stuart Stoller of Sterling Heights, MI is reported in the CMS Open Payments database as having received $4,501 across 268 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $136,265 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 89th percentile of Family Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

2 rows
Year Kind Relative to this record's peak year Amount Records
2020 General $645 72
2019 General $3,856 196

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Stuart Stoller
  • Family Medicine median
  • Middle half of Family Medicine
  • National median

In program year 2025, general payments to Stuart Stoller were reported at $0. Among 56,786 Family Medicine profiles paid that year, the median was $155 and the middle half received between $45 and $549.

Show as a table
Year Stuart Stoller Family Medicine median Middle half National median
2019 $3,856 $150 $41–$543 $163
2020 $645 $120 $32–$415 $114
2021 $0 $137 $35–$551 $132
2022 $0 $137 $37–$512 $149
2023 $0 $149 $42–$545 $160
2024 $0 $156 $44–$560 $164
2025 $0 $155 $45–$549 $169

Breakdown

Who paid General payments · program years 2019–2020
  1. Novo Nordisk AS $1,844 6 payments
  2. Boehringer Ingelheim Pharmaceuticals, Inc. $492 19 payments
  3. Novo Nordisk Inc $422 84 payments
  4. Amgen Inc. $279 18 payments
  5. Sunovion Pharmaceuticals Inc. $202 26 payments
  6. Lilly USA, LLC $199 32 payments
  7. Janssen Pharmaceuticals, Inc $196 17 payments
  8. Merck Sharp & Dohme Corporation $192 18 payments
  9. Pfizer Inc. $180 17 payments
  10. Amarin Pharma Inc. $138 9 payments
  11. Other $355 22 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2020
  1. Food and Beverage $3,001 262 payments
  2. Travel and Lodging $1,482 4 payments
  3. Education $17 2 payments
Products named General payments · program years 2019–2020
  1. Ozempic $2,192 76 payments
  2. SPIRIVA RESPIMAT $304 20 payments
  3. XARELTO $196 17 payments
  4. STEGLATRO $192 18 payments
  5. JANUVIA $192 18 payments
  6. TRULICITY $190 31 payments
  7. LONHALA MAGNAIR $186 25 payments
  8. Repatha $174 11 payments
  9. RYBELSUS $173 36 payments
  10. INVOKANA $172 15 payments
  11. Other $2,467 237 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

268 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Family Medicine in Michigan

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2020

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record